Roche builds strength in molecular diagnostics

Share this article:

Roche has scooped up DNA sequencing firm Genia Technologies, reports the Wall Street Journal. The deal includes $125 million in an upfront payment, and the WSJ notes Monday's deal synchs with its acquisition of the molecular diagnostics firm IQuum and Roche's efforts to bolster its standing in this diagnostics space.

Roche attempted a hostile takeover of San Diego-based DNA sequencing firm Illumina in 2012. Illumina CEO Jay Flatley rallied stockholders to reject the takeover.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters